(Total Views: 286)
Posted On: 07/13/2017 5:46:58 PM
Post# of 72446
Great post from BioHedge on the other board BEFORE the top line results. I like his 10x short term and 100x long term projection!
BioHedge
Thursday, 07/13/17 12:30:42 PM
Re: None
Post # of 190063
IPIX's share-price will move on news of a deal or some other form of significant equity injection. I don't think study results will do it unless it's the P IIb (which has undeniable scientific merit). The science has done nothing but impress over the past five years, but unfortunately, the short and distorts have owned the narrative of this company.
I believe a 50% or better remission rate with the final cohort today will enable IPIX to see a deal within 90 days for B-UP. The biggest hurdle to that deal will be trying to sell or license only one indication as opposed to the entire platform. So whether they take the deal is anyone's guess.
90 days is a short amount of time to wait for such a significant possible return. This is not just a 20% return. I'm looking for a short term 10x and long term 100x. If the data continues to prove out a BP will make a play. The data is becoming to hard to ignore and these drugs are playing in BIG spaces.
BioHedge
Thursday, 07/13/17 12:30:42 PM
Re: None
Post # of 190063
IPIX's share-price will move on news of a deal or some other form of significant equity injection. I don't think study results will do it unless it's the P IIb (which has undeniable scientific merit). The science has done nothing but impress over the past five years, but unfortunately, the short and distorts have owned the narrative of this company.
I believe a 50% or better remission rate with the final cohort today will enable IPIX to see a deal within 90 days for B-UP. The biggest hurdle to that deal will be trying to sell or license only one indication as opposed to the entire platform. So whether they take the deal is anyone's guess.
90 days is a short amount of time to wait for such a significant possible return. This is not just a 20% return. I'm looking for a short term 10x and long term 100x. If the data continues to prove out a BP will make a play. The data is becoming to hard to ignore and these drugs are playing in BIG spaces.
(0)
(0)
